To News

Woodbridge International Welcomes New Medical Diagnostics Dealmaker

October 8, 2014

Woodbridge International, a global mergers and acquisitions firm specializing in middle-market transactions, is pleased to welcome Lawrence A. Siebert as its new Senior M&A Advisor specializing in the Medical Diagnostics industry. Larry will be managing sell-side and buy-side deals for Woodbridge clients worldwide operating in range of Diagnostics businesses.

Larry is a seasoned mergers and acquisitions advisor who has served as Chairman and Chief Executive Officer of Chembio Diagnostic Systems, Inc., a NASDAQ-listed developer and manufacturer of point-of-care, in-vitro diagnostic products. Among his many accomplishments at Chembio, Larry led the company to achieve 10 consecutive years of double-digit revenue growth and produced an internal rate of return for investors of approximately 40%.

Prior to leading Chembio, Larry headed up two boutique investment banking firms serving middle-market companies and completed dozens of M&A transactions for a variety of businesses. He holds a JD from Case Western Reserve University School of Law and a BA in Economics from The University of Connecticut.

Woodbridge is excited to have Larry on its team of senior M&A advisors and is pleased to offer industry expertise to sellers and buyers of companies providing Medical Testing, Analysis and Diagnostic Equipment, Microbiology Laboratory Services, Medical Laboratory Services, Medical Device Research Equipment and In Vivo Diagnostics.